Malondialdehyde levels increased 3-fold in the PP group and 2-fold in the PP-ABH group compared with controls.
Only a small decrease in affinity (of ∼10-fold) of pp-SFRS1 toward Ron ESE mRNA is observed.
Lung injury scores were 4.8-fold higher in the PP group and 2-fold higher in the PP-ABH group compared with controls (P <0.001 and P <0.01, respectively).
The chain folding energy for PP crystallization (σe) decreases with fibre content, and a minimum is observed at 20% fibre content.
The half-crystallization times (τ12) as well as the Avrami exponent (n) and the chain folding energy for PP crystallization (σe) increase markedly at LDPE percentages above 10% in the blend.
The total lung injury scores (sum of cellularity, protein exudate, and hemorrhage scores) were 4.8-fold higher in the PP group (P <0.001) and 2-fold higher in the PP-ABH group (P <0.01) compared to the control group.
Among those, the nonconservative BRIP1 P919substitutionon showed a strong association with 4.5-fold and 6.9-fold (for PS and PP vs. SS, respectively) increased risks of breast cancer up to age 50.
Interestingly, these results were confirmed by qRT-PCR, but the induction was much higher than that observed in the microarray experiment, reaching an over 12-fold increase at the PP stage and an approximately 88-fold increase at the P stage.
As pp-fold implied a greater reduction in terms of training population compared to k-fold, a pp-like strategy was also tested, in order to ensure the same training population size is used in both schemes.
These were oxidized to form a cysteine disulfide bond locking the peptides into the PP-fold structure.
Nuclear magnetic resonance (NMR) and X-ray crystallography studies have shown these peptides can adopt a tightly organized tertiary structure called the PP-fold, which has long been assumed to be the active structure of this family of peptides.
